Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sanders, Melinda E."'
Autor:
Pareja F; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., da Silva EM; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Frosina D; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Geyer FC; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lozada JR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Basili T; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Da Cruz Paula A; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhong E; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Derakhshan F; Department of Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada., D'Alfonso T; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wen HY; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Giri DD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hayes MM; Department of Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada., Krings G; Department of Pathology at Mission Bay, University of California San Francisco, San Francisco, CA, USA., Bhargava R; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Palazzo JP; Department of Pathology, Baptist Health South Florida, Miami, FL, USA., Rakha EA; Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, UK., Hoda SA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Sanders ME; Department of Pathology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA., Collins LC; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Schnitt SJ; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School; Dana-Farber Cancer Institute, Boston, MA, USA., Chen YY; Department of Pathology at Mission Bay, University of California San Francisco, San Francisco, CA, USA., Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jungbluth AA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. reisfilj@mskcc.org., Brogi E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. brogie@mskcc.org.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2020 Jun; Vol. 33 (6), pp. 1056-1064. Date of Electronic Publication: 2020 Jan 02.
Autor:
Lehmann BD, Bauer JA, Schafer JM, Pendleton CS, Tang L, Johnson KC, Chen X, Balko JM, Gómez H, Arteaga CL, Mills GB, Sanders ME, Pietenpol JA
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2014 Aug 08; Vol. 16 (4), pp. 406. Date of Electronic Publication: 2014 Aug 08.
Autor:
Abramson VG; Department of Medicine, Vanderbilt University School of Medicine, 2220 Pierce Ave, 777 PRB, Nashville, TN, 37232, USA, vandana.abramson@vanderbilt.edu., Cooper Lloyd M, Ballinger T, Sanders ME, Du L, Lai D, Su Z, Mayer I, Levy M, LaFrance DR, Vnencak-Jones CL, Shyr Y, Dahlman KB, Pao W, Arteaga CL
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2014 Jun; Vol. 145 (2), pp. 389-99. Date of Electronic Publication: 2014 Apr 11.
Autor:
Balko JM; Vanderbilt University Medical Center, 2200 Pierce Ave, 777 PRB, Nashville, TN 37232-6307, USA., Mayer IA, Sanders ME, Miller TW, Kuba MG, Meszoely IM, Wagle N, Garraway LA, Arteaga CL
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2012 Oct; Vol. 11 (10), pp. 2301-5. Date of Electronic Publication: 2012 Aug 09.
Autor:
Monica V. Estrada, Dejan Juric, Carlos L. Arteaga, Luigi Formisano, Lewis C. Cantley, David B. Solit, Helen Won, Melinda E. Sanders, Michael F. Berger, Yisheng Li, Justin M. Balko, Vandana G. Abramson, Ingrid A. Mayer, Eric P. Winer
Purpose: Alpelisib, a selective oral inhibitor of the class I PI3K catalytic subunit p110α, has shown synergistic antitumor activity with endocrine therapy against ER+/PIK3CA-mutated breast cancer cells. This phase Ib study evaluated alpelisib plus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8336724711550ce626edc119aec5689d
https://europepmc.org/articles/PMC5085926/
https://europepmc.org/articles/PMC5085926/